Takayasu's arteritis presenting with temporary loss of vision in a 23-year-old woman with beta thalassemia trait: a case report by Ishaq, Mohammad G & Shabbir, Fahad A
CASE REPORT Open Access
Takayasu’s arteritis presenting with temporary
loss of vision in a 23-year-old woman with beta
thalassemia trait: a case report
Mohammad G Ishaq and Fahad A Shabbir
*
Abstract
Introduction: The simultaneous presence of Takayasu’s arteritis and beta thalassemia trait is a rare combination. To
the best of our knowledge, this is the first case report on Takayasu’s arteritis and beta thalassemia presenting
together.
Case presentation: This is a case report of a 23-year-old Asian woman of Pakistani descent who presented with a
headache, blurred vision and dizziness.
Conclusion: The correct diagnosis of our patient was based on clinical suspicion, appropriate imaging studies, and
deliberation of the differential diagnosis. The management of our patient depended on the correct diagnosis of
both the diseases.
Introduction
Takayasu’s arteritis (TA) is an autoimmune, chronic,
progressive, large-vessel vasculitis that usually affects
young adults, especially women. The disease can affect
all races and ethnic groups. The diffuse nature of this
vasculitis can involve multiple organ systems to varying
degrees and can present with a wide range of symptoms
[1], with an incidence of one to two cases per million
people per year [2]. Beta thalassemia trait is an autoso-
mal recessive disorder characterized by a point mutation
on the beta-globin chain gene on chromosome 11,
resulting in the defective synthesis of the beta-globin
chain of hemoglobin [3]. To the best of our knowledge,
the incidence of TA with beta thalassemia trait has not
previously been reported in the literature.
Case Presentation
A 23-year-old Asian woman of Pakistani descent pre-
sented with blackouts, blurring of vision and headache for
more than two months duration. The headaches started in
the frontal region then radiated to the whole head, were
moderate in intensity and were associated with vertigo,
dizziness, palpitations and postural weakness. Her past
medical history revealed that she had been diagnosed with
epilepsy two months previously, after which she had been
given antiepileptic medication. She had been using the
medication regularly since being diagnosed. On general
examination, pulses in both her upper limbs were deficient
and so her blood pressure could not be measured. Our
patient was also found to be anemic. On cardiovascular
examination a bruit was heard over her left subclavian
fossa. Fundoscopy revealed optic disk cupping with irregu-
lar margins in her right eye; her left eye was unaffected.
All other examination, including respiratory and central
nervous system examinations, were unremarkable. A psy-
chiatric evaluation was also inconclusive.
Our patient had anemia (hemoglobin 10 g/dL), throm-
bocytosis (494,000/mL) and raised erythrocyte sedimen-
tation rate (ESR) (35 mm/hr). The morphology of the
red blood cells showed microcytosis and hypochromasia.
An investigation into the serum ferritin revealed that it
was well above the normal range (315.5 ng/mL). Hemo-
globin electrophoresis presented with a mean corpuscu-
lar volume of 58.7 fL, mean corpuscular hemoglobin of
19.2 pg, and hemoglobin A2 of 4.7%. Liver enzymes
were significantly raised (direct bilirubin 0.3 mg/dL, ala-
nine transaminase 152 U/L, alkaline phosphatase 317 U/
L). The C-reactive protein test was also reactive. In
addition the following investigations were unremarkable:
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antinuclear antibodies, electrocardiogram, echocardio-
graph and electroencephalogram (EEG).
A computed tomography angiogram (CT-A) of her
chest showed a normal ascending aorta, descending
aorta and arch of the aorta but there was diffuse intimal
thickening of major branches of the aorta including the
brachiocephalic, right common carotid, and left subcla-
vian arteries (Figure 1). There was extensive collateral
circulation in the subcutaneous tissue in her anterior
and posterior neck, chest and axillae.
Our patient had been taking antiepileptic medication
for over a month. This was immediately halted because
her liver enzymes were elevated above normal range;
this decision was also supported by the negative results
of the EEG report (the alpha wave was present on clo-
sure of eye and had a frequency of 10 cycles per second;
which disappeared when the patient was instructed to
open her eyes, beta, theta and delta waves had frequen-
cies of 14, 5 and 3 cycles per second). Our patient was
kept on one milligram per kilogram bodyweight per day
of corticosteroid and was kept under a weekly follow-up
for two months to monitor her response to the treat-
ment. Our patient is responding well.
Discussion
Based on the clinical history, examination, imaging stu-
dies and serum electrophoresis our patient was diag-
nosed with Type I TA with beta thalassemia trait. TA
may present with nonspecific symptoms such as fever,
arthralgia and weight loss. It may also present with sys-
temic complaints depending on the site of involvement;
for example neurological symptoms like dizziness (33%)
and impairment of vision (20-30%), carotid bruit (70%),
deficit of upper limbs pulses (53%) and the deficit of
other pulses, all of which were seen on examination of
our patient [4]. Patients with TA may also present with
epilepsy [5]. Fifty percent of patients with TA have a
normal ESR [6]. Patients with beta thalassemia trait also
have a raised ESR. Anemia in TA can be normocytic
and normochromic, but our patient presented with
microcytic hypochromic anemia which is commonly due
to an iron deficiency in females of reproductive age in
this part of the world [7]. To further confirm our diag-
nosis of beta thalassemia, a serum electrophoresis was
done to firmly establish that the anemia was due to beta
thalassemia trait and to exclude iron deficiency anemia.
The differential diagnosis of TA may include congeni-
tal tissue matrix disorders (Marfan and Ehler-Danlos
syndromes), infectious large vessel aneurysm (mycobac-
terial, syphilitic, or fungal) and autoimmune diseases
(systemic lupus, Cogan syndrome and Behçet’s disease);
however these disorders were ruled out because they are
not associated with large vessel stenosis as seen in TA.
Large vessel vasculitis was ruled out because it is asso-
ciated with the advanced age (Kawasaki disease and
giant-cell arteritis). Sarcoidosis is also considered as a
differential of TA, but is only diagnosed after all the dif-
ferentials have been ruled out.
Current studies postulate that non-invasive imaging
techniques are very helpful in the early diagnosis of TA,
such as magnetic resonance imaging, ultrasound and
18F-fluorodeoxyglucose positron emission tomography.
In comparison to standard angiography, they also pro-
vide a tool for a comprehensive monitoring of the dis-
ease [8]. Treatment of TA is a real challenge for the
clinicians and in spite of current treatment vascular
lesions develop frequently. Remission occurs in patients
using immunosuppressive drugs (for example metho-
trexate) along with corticosteroids, but unfortunately
reactivation is common when the dose of corticosteroids
is brought down. The use of surgical and endovascular
procedures are safe and associated with low mortality
and morbidity. Good results have been achieved using
bypass grafts, whereas percutaneous transluminal angio-
plasty gives better results for smaller lesions. Conven-
tional stents used in vessel patency are just not good
enough in the long-term [9]. The use of tumor necrosis
Figure 1 CT-A of arch of the aorta and its major branches
showing diffuse intimal thickening, with narrowing of the
origins of major branches of the arch of the aorta involving
brachiocephalic, right common carotid and left subclavian
arteries.
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has been shown to improve prognosis in severe disease.
Initial results show promising outcomes and higher
chances of therapeutic success may be attained by
newer drugs like rapamycin (sirolimus) and everolimus.
These drugs inhibit myointimal proliferation thereby
effectively inhibiting vessel intimal hyperplasia and indu-
cing expression of heme oxygenase-1 [10].
Beta thalassemia trait is not treated actively; erythro-
poesis is ineffective and down-regulation of iron absorp-
tion is also altered. Thus occurs because of an excess of
the growth differentiation factor 15 (GDF-15), which is
produced by the erythroid tissue of the bone marrow.
GDF-15 inhibits hepcidin gene expression, which in
turn increases iron absorption from the gastrointestinal
tract [11]. Hence the use of oral iron supplementation
should be monitored by measuring the serum ferritin
levels at regular intervals. Beta thalassemia trait is not a
life-threatening condition but can affect the quality of
life due to mild or moderate anemia and should only be
treated if the patient becomes symptomatic. The coexis-
tence of other disease with beta thalassemia trait has
been shown in studies including asthma [12] and mood
disorders [13]. Genetic counseling is an essential part of
managing such patients in our setting, where beta tha-
lassemia trait testing is not done routinely.
Conclusion
The simultaneous occurrence of TA and beta thalasse-
mia trait is a rare incidence which has not previously
been reported; therefore it is important that such a case
be presented in the international literature as a refer-
ence point. Clinical suspicion, appropriate imaging, and
the consideration of the differential diagnosis are impor-
tant for the correct diagnosis and management of
patients with TA and beta thalassemia trait.
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